Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
New research on cancer vaccines from Soochow University summarized
March 19th, 2008
In this recent report published in the World Journal of Gastroenterology, researchers in Suzhou, People's Republic of China conducted a study "To investigate the effect of a vaccine with recombinant adenovirus interleukin-12 (AdVIL-12) transduced dendritic cells (DCs) against colon cancer in mice. DCs and AdVIL-12 were incubated together at different time intervals and at different doses." "Supernatant was collected and tested for IL-12 by enzyme-linked immunosorbent assay (ELISA). In order to determine whether tumor cell lysate-pulsed (TP) AdVIL-12/DCs enhance therapeutic potential in the established tumor model, CT26 colon tumor cells were implanted...
Source: Vaccine Weekly (2008-03-19)
|
